Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Natarajan Harivenkatesh"'
Publikováno v:
Clinical Epidemiology and Global Health, Vol 26, Iss , Pp 101536- (2024)
Background: Prevalence studies on major depression and dysthymia are plentiful at the community level in India. Hospital-based studies are few and none in Puducherry. This study aims to find the proportions of major depression and dysthymia and their
Externí odkaz:
https://doaj.org/article/0b32673294234b14aa203523c916b425
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Natarajan, Harivenkatesh1, Kumar, Lalit2, Bakhshi, Sameer2, Sharma, Atul2, Gogia, Ajay2, Velpandian, Thirumurthy3, Ranjan Biswas, Nihar3, Gupta, Yogendra Kumar3, Kabra, Madhulika4
Publikováno v:
Leukemia & Lymphoma. Feb2019, Vol. 60 Issue 2, p418-425. 8p.
Autor:
Mathaiyan, Jayanthi1 (AUTHOR), Natarajan, Harivenkatesh1 (AUTHOR), Parameswaran, Narayanan2 (AUTHOR), Suthakaran, C3 (AUTHOR)
Publikováno v:
Journal of Pharmacology & Pharmacotherapeutics. Oct-Dec2020, Vol. 11 Issue 4, p145-147. 3p.
Autor:
Natarajan, Harivenkatesh1 (AUTHOR), Mathaiyan, Jayanthi1 (AUTHOR), Ramasamy, Raveendran1 (AUTHOR)
Publikováno v:
Journal of Pharmacology & Pharmacotherapeutics. Oct-Dec2020, Vol. 11 Issue 4, p142-144. 3p.
Autor:
Nihar Ranjan Biswas, Yogendra Kumar Gupta, Natarajan Harivenkatesh, Thirumurthy Velpandian, Atul Sharma, Ajay Gogia, Shivaram Shastri, Lalit Kumar, Sameer Bakhshi, Madhulika Kabra
Publikováno v:
Pharmacological Research. 120:138-145
Polymorphisms in genes coding for imatinib transporters and metabolizing enzymes may affect imatinib pharmacokinetics and clinical response. Aim of this study was to assess the influence of polymorphisms in MDR1 and CYP3A5 genes on imatinib trough le
Autor:
Madhulika Kabra, Sameer Bakhshi, Thirumurthy Velpandian, Lalit Kumar, Shivaram Shastri, Ajay Gogia, Natarajan Harivenkatesh, Atul Sharma, Yogendra Kumar Gupta
Publikováno v:
Leukemia & Lymphoma. 58:2218-2226
Influence of polymorphisms in the genes coding for imatinib transporters and metabolizing enzymes on cytogenetic relapse in patients with chronic myeloid leukemia (CML) is not known. One hundred and four patients (52 cases with cytogenetic relapse an
Autor:
Natarajan Harivenkatesh, Muthiah Kothandaramanujam Sudhakar, Darling Chellathai David, Natarajan Haribalaji
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 19:296-303
Introduction: The long half-life of atorvastatin and fenofibrate makes them suitable for alternate day therapy. Hence, we aimed to study the efficacy, safety, and cost-effectiveness of alternate day therapy with atorvastatin and fenofibrate combinati
Autor:
Rockson, Christopher1,2 (AUTHOR), Girish, Chandrashekaran1 (AUTHOR) JD1170@jipmer.ac.in, Natarajan, Harivenkatesh1 (AUTHOR), Menon, Vikas3 (AUTHOR)
Publikováno v:
Indian Journal of Psychological Medicine. Sep2024, p1.